EcoDrugPlus

Adrenoceptor Alpha 1b

Ensembl ID : ENSTRUG00000008130
Gene Symbol: ADRA1B
1 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSTRUG00000002804
Gene Symbol: ADRA1D
4 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSTRUG00000033092
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSTRUG00000003591
Gene Symbol: ADRA2C
2 Cross references
160 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSTRUG00000023439
Gene Symbol: ADRA2C
1 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSTRUG00000012396
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSTRUG00000014131
Gene Symbol: ADRB2
3 Cross references
192 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSTRUG00000025310
Gene Symbol: ADRB3A
1 Cross references
196 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSTRUG00000016809
Gene Symbol: AKR1B1.1
1 Cross references
345 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSTRUG00000016818
Gene Symbol: AKR1B1.2
1 Cross references
343 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSTRUG00000001540
Gene Symbol: GAA
1 Cross references
232 Possible Orthologues:

Alpha-2a Adrenergic Receptor

Ensembl ID : ENSTRUG00000018599
Gene Symbol: LOC101069434
3 Cross references
149 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).